Study assessing vaccination responses in HIV+ and HIV- individuals to assess the utility of quantifying antibodies to guide booster timing
Latest Information Update: 01 Feb 2023
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 01 Feb 2023 New trial record